NSEAnalysts/Institutional Investor Meet/Con. Call Updates15 Sept 2026
Patanjali Foods Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Patanjali Foods Limited has informed the Exchange about the schedule of an investor conference and one-on-one/group meetings with investors on September 18, 2026, in Gurugram. The meeting will not disclose any price-sensitive information or forward-looking statements.
BSECompany UpdateMgmt Change15 Sept 2026
L&T Technology Services Ltd
L&T Technology Services Limited has informed the exchange about schedule of meet.
L&T Technology Services Ltd has informed the exchange about its schedule of analyst/institutional investor meetings.
BSECompany UpdateMgmt Change15 Sept 2026
ASTRAZENECA PHARMA INDIA LIMITED
ASTRAZENECA PHARMA INDIA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
AstraZeneca Pharma India Limited has informed the BSE about the cessation of a director, Medical Affairs, Biopharmaceutical Business Unit, and Rare Disease Business Unit.
BSECompany UpdateMgmt Change15 Sept 2026
ASTRAZENECA PHARMA INDIA LIMITED
ASTRAZENECA PHARMA INDIA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
AstraZeneca Pharma India Limited has informed the BSE about the cessation of a director, specifically the Director - Medical Affairs, Biopharmaceutical Business Unit and Rare Disease Business Unit.
BSECompany UpdateMgmt Change15 Sept 2026
IFCI Limited
IFCI Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
IFCI Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change15 Sept 2026
IFCI Limited
IFCI Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
IFCI Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateFundraise15 Sept 2026
Mayur Leather Products Ltd
Bonanza Portfolio Limited ("Manager to the Offer") has submitted to BSE a copy of Public Announcement (''PA'') under Regulation 3(1) and 4 read with 13, 14 and 15(1) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments thereof for the attention of the Public Shareholders of Mayur Leather Products Ltd ("Target Company").
Mayur Leather Products Ltd has received a public announcement from Bonanza Portfolio Limited regarding an open offer for up to 12,57,048 equity shares, representing 26% of the company's equity and voting share capital, at an offer price of ₹27.92 per share.
NSETrading WindowRegulatory15 Sept 2026
AstraZeneca Pharma India Limited
Trading Window
AstraZeneca Pharma India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window will be closed from September 16, 2026, and will reopen after 48 hours from the declaration of Un-audited Financial Results of the Company for the quarter and half year ending September 30, 2026.
BSECompany UpdateJoint Venture15 Sept 2026
Thermax Ltd
Thermax Limited has informed the Exchanges about incorporation of wholly owned step-down subsidiary.
Thermax Ltd has informed the exchanges about the incorporation of a wholly owned step-down subsidiary, Thermax Botswana Proprietary Limited, in Botswana.
BSEAGM/EGMMgmt Change15 Sept 2026
Fineotex Chemical Ltd
Voting Results and Scrutinizer''s Report on 23rd Annual General Meeting held on September 11, 2026
Fineotex Chemical Ltd has announced the voting results and scrutinizer's report for its 23rd Annual General Meeting held on September 11, 2026. All resolutions were passed with 100% approval from promoters and 99.99% approval from public shareholders.
BSEGeneralRegulatory15 Sept 2026
UltraTech Cement Ltd
Regulation 30(11) of the SEBI (LODR) Regulations, 2015
UltraTech Cement Ltd has issued a clarification regarding a material price movement in its share price on September 15, 2026, stating that it was purely market-driven and not triggered by any event or information.
NSEAcquisitionJoint Venture15 Sept 2026
Thermax Limited
Acquisition
Thermax Limited has informed the Exchange about the incorporation of a wholly owned step-down subsidiary, Thermax Botswana Proprietary Limited, in Botswana.
BSECompany UpdateMgmt Change15 Sept 2026
Bank of India
Analyst/Investor meet on 15.09.2026
Bank of India held an analyst/investor meet with Phillip Capital, disclosing only publicly available information and confirming no unpublished price sensitive information was shared.
NSEAnalysts/Institutional Investor Meet/Con. Call Updatesanalysts_institutional_investo15 Sept 2026
Bank of India
Analysts/Institutional Investor Meet/Con. Call Updates
Bank of India has informed the Exchange about an Analyst/Investor Meet as on 15-09-2026, where the bank's representative had a physical meeting with Phillip Capital, sharing only publicly available information and no unpublished price-sensitive information.
BSECompany Update15 Sept 2026
Jupiter Life Line Hospitals Ltd
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure requirements) Regulations 2015.
Jupiter Life Line Hospitals Ltd has announced the schedule of analyst/institutional investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The meetings will be held on September 28, 2026, and will discuss publicly available information.
BSEInsider Trading / SAST15 Sept 2026
AstraZeneca Pharma India Ltd
Please find the enclosed intimation of the Company as per the captioned subject for your reference.
AstraZeneca Pharma India Ltd has announced the closure of its trading window from September 16, 2026, until 48 hours after the declaration of its un-audited financial results for the quarter and half year ending September 30, 2026.
NSEAppointmentMgmt Change15 Sept 2026
IFCI Limited
Appointment
IFCI Limited has appointed Mr. Dilip Singh Punia as a Non-Executive Independent Director on its board, effective September 11, 2026, for a period of three years.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesMgmt Change15 Sept 2026
L&T Technology Services Limited
Analysts/Institutional Investor Meet/Con. Call Updates
L&T Technology Services Limited has informed the Exchange about its participation in the Anand Rathi Annual Flagship Conference and G-200 Summit, where it will make a presentation on its business. The company has disclosed this information pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates15 Sept 2026
Escorts Kubota Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Escorts Kubota Limited has informed the Exchange about Schedule of Analyst/ Investor Meet, with investor meetings scheduled from September 21 to September 25, 2026, and an Investor & Earning Presentation available on the company's website.
BSECompany UpdateMgmt Change15 Sept 2026
Escorts Kubota Ltd
Intimation of Schedule of Analyst/ Investor Meet
Escorts Kubota Ltd has announced the schedule of an analyst/investor meet, which includes group meetings with various investors, a plant visit, and one-on-one meetings. The meet is scheduled from September 21 to 25, 2026, and no unpublished price-sensitive information will be shared.